1. Home
  2. CDIO vs FBGL Comparison

CDIO vs FBGL Comparison

Compare CDIO & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

N/A

Current Price

$1.93

Market Cap

6.1M

Sector

Health Care

ML Signal

N/A

Logo FBS Global Limited Ordinary Shares

FBGL

FBS Global Limited Ordinary Shares

N/A

Current Price

$0.39

Market Cap

5.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
CDIO
FBGL
Founded
2017
1996
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
5.3M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
CDIO
FBGL
Price
$1.93
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.8K
130.2K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,825.00
N/A
Revenue This Year
$171,906.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.97
$0.34
52 Week High
$7.91
$1.40

Technical Indicators

Market Signals
Indicator
CDIO
FBGL
Relative Strength Index (RSI) 60.58 37.72
Support Level $1.68 $0.35
Resistance Level $2.30 $0.64
Average True Range (ATR) 0.11 0.03
MACD 0.02 0.00
Stochastic Oscillator 84.72 3.38

Price Performance

Historical Comparison
CDIO
FBGL

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply, and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture, as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and sales of construction materials.

Share on Social Networks: